Related Experiment Video
Updated: Mar 10, 2026

Full-root Aortic Valve Replacement by Stentless Aortic Xenografts in Patients with Small Aortic Roots
Published on: May 21, 2017
Anticoagulation After Biological Aortic Valve Replacement: Is There An Optimal Regimen?
Tamer Owais1, Mina Rouman1, Martin Breuer1
1Department of Cardiac Surgery and Cardiology, Central Clinic of Bad Berka, Germany.
For biological aortic valve replacement (BAVR), aspirin showed lower bleeding risk and similar survival compared to warfarin. Aspirin is a safer alternative for early postoperative anticoagulation after BAVR.
Area of Science:
- Cardiology
- Cardiovascular Surgery
- Pharmacology
Background:
- Anticoagulation after biological heart valve replacement is debated due to thrombosis risks.
- Guidelines recommend warfarin post-biological aortic valve replacement (BAVR), but evidence is debated.
- Current guidelines lack clear risk-benefit data for early anticoagulation post-BAVR.
Purpose of the Study:
- To compare aspirin and warfarin efficacy in patients post-BAVR.
- To evaluate bleeding, ischemic events, and survival rates.
- To determine optimal anticoagulation strategy in the early postoperative phase.
Main Methods:
- 863 patients undergoing BAVR were randomized into two groups.
- One group received warfarin (n=430), the other aspirin (n=433) for three months.
- Primary endpoints included bleeding, cerebral ischemic events, and survival.
Main Results:
- Aspirin showed a statistically lower risk of postoperative bleeding.
- Cerebral ischemic events were comparable between groups in the short term.
- No significant differences in stroke-free or overall survival were observed.
Conclusions:
- Warfarin anticoagulation is statistically inferior to aspirin for bleeding risk post-BAVR.
- Aspirin demonstrates comparable efficacy and improved safety over warfarin.
- Platelet inhibition with aspirin is a potentially safer early anticoagulation strategy post-BAVR.
More Related Videos
Related Concept Videos
Aortic Regurgitation III: Medical Management
Aneurysm IV: Nursing Management
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Aortic Regurgitation I: Introduction
Aneurysm III: Interprofessional Care

